The effect of vagus nerve stimulator in controlling status epilepticus in children

Area of Science:

• Neurology
• Pediatric Epilepsy
• Neurosurgery

Background:

• Medically intractable epilepsy in children poses significant management challenges.
• Status epilepticus (SE) is a severe manifestation of epilepsy with potential for long-term neurological sequelae.
• Vagus Nerve Stimulation (VNS) is an established neuromodulatory therapy for refractory epilepsy.

Purpose of the Study:

• To investigate the efficacy of Vagus Nerve Stimulator (VNS) in reducing the frequency and severity of Status Epilepticus (SE) in pediatric patients with medically intractable epilepsy.
• To evaluate the impact of VNS on overall seizure burden, specifically generalized convulsive seizures, in this patient cohort.

Main Methods:

• Retrospective chart review of pediatric patients with a history of at least two SE events.
• Inclusion criteria required VNS implantation and a minimum of one year of post-operative follow-up.
• Data analysis focused on seizure frequency and SE occurrence before and after VNS implantation.

Main Results:

• 16 patients met the study criteria, with a median age of 1.3 years at seizure onset and 9.0 years at VNS surgery.
• Prior to VNS, 81% experienced monthly seizures, and 75% had monthly generalized convulsive seizures.
• One year post-VNS, the proportion of patients with no SE increased significantly (75% vs. 37%, p=0.07). Generalized convulsive seizure frequency decreased in 69% at one year (p=0.01).

Conclusions:

• Vagus Nerve Stimulation demonstrates a favorable impact on reducing Status Epilepticus in children with medically intractable epilepsy.
• VNS therapy is effective in decreasing the frequency of generalized convulsive seizures in this challenging pediatric population.
• The findings support VNS as a valuable therapeutic option for managing severe epilepsy syndromes in children.